MLAB Stock Analysis: Buy, Sell, or Hold?
MLAB - Mesa Laboratories Inc
$89.62
1.16 (1.31%)
▲
5d:
+9.63%
30d:
-3.46%
90d:
+14.17%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Jun 02, 2026
Get Alerted When MLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MLAB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: MLAB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.49
Based on -11.4% avg growth
INTRINSIC VALUE TODAY
$24.52
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MLAB is currently trading at $89.62, which is considered slightly high relative to its 30-day fair value range of $79.65 to $92.19. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.4) compared to its historical average (13.9). At these levels, the market is pricing in 5.8% annual earnings growth.
Technical Outlook: Technically, MLAB is in a uptrend. The price is approaching resistance at $91.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MLAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $104.50 (+18.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MLAB is in a uptrend. The price is approaching resistance at $91.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MLAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $104.50 (+18.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$79.65 -
$92.19
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($104.50)
- BULLISH: Expecting earnings turnaround to 5.8% growth with 3.6% revenue growth
Fair Price Analysis
30-Day Fair Range
$79.65 -
$92.19
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$79.38
Resistance Level
$91.02
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.41
Wall Street Target
$104.50
(+18.1%)
Revenue Growth (YoY)
3.6%
Earnings Growth (YoY)
-28.7%
Profit Margin
1.5%
Valuation Premium vs History
+5.8% premium
PE vs Historical
16.4 vs 13.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.8%
(market-implied from PE analysis)
1-Year Target
$93.59
(+6%)
2-Year Target
$99.02
(+12%)
3-Year Target
$104.76
(+18%)
3-Yr Target (if PE normalizes)
(PE: 16→14)
PE COMPRESSION
$88.73
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: -26.7%)
$87.82
(+-1%)
Base:
(SPY PE: 16.4, Growth: -26.7%)
$64.49
(-27%)
Bear:
(PE: 13.9, Growth: -26.7%)
$54.62
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Forward PE: 35.21 | Forward EPS (Implied): $2.34
Bull Case
$99.50
(+21%)
Analyst growth 15.0%, PE expands to 37.0
Base Case
$82.40
(0%)
Market implied 0.0%, PE stable at 35.2
Bear Case
$63.04
(-24%)
Severe decline -15.0%, PE contracts to 31.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: April 02, 2026 1:58 PM ET
Data refreshes hourly during market hours. Next update: 2:58 PM
Data refreshes hourly during market hours. Next update: 2:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLAB showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Mark Christopher Capone
BUY
1301 shares
2026-03-10
R Tony Tripeny
BUY
1315 shares
2026-03-10
Shiraz Shabanali Ladiwala
BUY
3500 shares
2026-03-10
Top Rated Scientific & Technical Instruments Stocks
Top-rated stocks in Scientific & Technical Instruments by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
COHR
Coherent Inc |
STRONG BUY
19 analysts |
$284 | 47 HOLD |
|
FTV
Fortive Corp |
BUY
20 analysts |
$63 | 65 BUY |
|
TRMB
Trimble Inc |
STRONG BUY
12 analysts |
$91 | 59 HOLD |
|
MKSI
MKS Instruments Inc |
STRONG BUY
12 analysts |
$292 | 59 HOLD |
|
CGNX
Cognex Corporation |
BUY
20 analysts |
$66 | 53 HOLD |
